HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
iSTAR Medical MIGS Device Studies: Highly Promising in Glaucoma Patients
The two-year final outcomes from STAR-I trial and six-month results from its European trial STAR-II have been accepted for presentation at the European Glaucoma Society meeting, now postponed to December 2020 following the Covid-19 pandemic.
Thrive Earlier Detection Announces Groundbreaking Clinical Data from the First Ever Interventional Study of a Blood-Based Test to Screen and Identify Multiple Types of...
The study was conducted by Johns Hopkins University and Geisinger and enrolled more than 10,000 women with no prior history of cancer notes Thrive Earlier Detection.
Medtronic Onyx ONE Clear Study of One-Month Dual-Antiplatelet Therapy in High Bleeding Risk Stent Patients Beats Performance Goal
Medtronic Onyx ONE Clear Study met its primary endpoint of cardiac death or myocardial infarction by beating a performance goal derived from contemporary one-month DAPT trials at one-year post-procedure.
Study Shows Sense of Touch Can Be Returned to Those with Spinal Cord Injury
The Sense of Touch findings was reported in the prestigious scientific journal, Cell.
Eurofins – Transplant Genomics Announces TRULO Registry Study to Evaluate Long-Term Clinical Outcomes in Patients Monitored with TruGraf® Testing
TRULO is a prospective, multicenter observational registry study, designed to evaluate post-transplant clinical outcomes in recipients of kidney transplants who are undergoing serial TruGraf testing notes Eurofins.
New Clinical Study Results Demonstrate Rezūm is Proven to Give Men Suffering with BPH Sustained Symptom Relief and Quality of Life Improvements for 5...
The supplement, available online now, includes standard and late-breaking abstracts for the American Urological Association (AUA) Annual Meeting.
Signatera Technology for Personalized Monitoring in Gastrointestinal Cancer Shows Benefits According to a New Study
A new, peer-reviewed case study published in JCO Precision Oncology1 demonstrates the unique ability of Signatera technology to detect esophageal cancer recurrence almost one year before current standards of care, using a simple blood draw to monitor for traces of circulating tumor DNA.
AMRA Medical and Fulcrum Therapeutics Develop MRI Method for Multi-site Neuromuscular Clinical Trials
In collaboration, AMRA Medical and Fulcrum Therapeutics created a standardized whole-body magnetic resonance imaging (MRI) protocol to evaluate skeletal muscle composition in patients with facioscapulohumeral dystrophy (FSHD) – a slowly progressing muscular dystrophy. An abstract describing this work was accepted and made publicly available by the Muscular Dystrophy Association.
Fractyl Laboratories Announces New REVITA-2 Study Clinical Data
Data presented at ENDO 2020 from the randomized, sham-controlled REVITA-2 study verifies that improvements in blood glucose control (HbA1C), insulin sensitivity, and other metabolic measures seen after one Revita treatment are also associated with improved pancreatic beta-cell function notes Fractyl Laboratories.